Treatment of Aplastic Anaemia with Methenolone
作者:
I.P. Palva,
C. Wasastjerna,
期刊:
Acta Haematologica
(Karger Available online 1972)
卷期:
Volume 47,
issue 1
页码: 13-20
ISSN:0001-5792
年代: 1972
DOI:10.1159/000208491
出版商: S. Karger AG
关键词: Anabolic hormones;Aplastic anaemia;Bone marrow failure;Methenolone therapy
数据来源: Karger
摘要:
Treatment of aplastic anaemia in 28 patients with oral methenolone 1–2 mg/kg for from 2 to 12 months resulted in normalisation of the blood count in 12 cases (43%). The remission rate was 60% for patients with a treatment period of at least 3 months. Cholestatic jaundice occurred in 2 cases (7%) but these recovered after discontinuing the drug. Other side effects were not severe enough to cause interruption of the treatment. There seems to be no doubt that methenolone by mouth is a useful treatment of patients with aplastic anaemia. The trial of therapy should be extended to at least 6 month
点击下载:
PDF
(1741KB)
返 回